Koyfin Home > Directory > Health Care > Boston Scientific Corp > EBITDA

Boston Scientific Corp EBITDA Chart (BSX)

Boston Scientific Corp annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Boston Scientific Corp EBITDA for the quarter ending June 06, 2020 was $242m a -178.51% decrease of -432m year over year
  • Boston Scientific Corp EBITDA for the last 12 months ending June 06, 2020 was $2,233m a -22.88% decrease of -511m year over year
  • Boston Scientific Corp Annual EBITDA for 2019 was $2,817m a 7.06% increase of 199m from 2018
  • Boston Scientific Corp Annual EBITDA for 2018 was $2,618m a 6.68% increase of 175m from 2017
  • Boston Scientific Corp Annual EBITDA for 2017 was $2,443m a 9.70% increase of 237m from 2016
Other Income Statement Metrics:
  • Boston Scientific Corp Net Income for the quarter ending December 12, 2018 was $386m a 22.80% increase of 88m year over year
  • Boston Scientific Corp Total Revenue for the quarter ending December 12, 2018 was $2,561m a 7.11% increase of 182m year over year
View Chart On Koyfin

Quarterly BSX EBITDA Data

06/2020$242m
03/2020$523m
12/2019$794m
09/2019$674m
06/2019$681m
03/2019$667m
12/2018$721m
09/2018$621m
06/2018$642m
03/2018$636m

Annual BSX EBITDA Data

2019$2,817m
2018$2,618m
2017$2,443m
2016$2,206m
2015$1,849m
2014$1,679m
2013$1,593m
2012$1,636m
2011$1,745m
2010$1,859m